Investors
Our investor proposition
GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical, vaccine and consumer healthcare products.
Key information
Annual Report 2019
We published our Annual Report 2019 on 04 March 2020. View the summary and download the full report or individual sections.
Latest information
Latest press releases
- Nucala (mepolizumab) is the first anti-IL5 biologic to report positive phase 3 results in patients with nasal polyps
- GSK completes divestment of Horlicks and other Consumer Healthcare nutrition products in India and certain other markets
- GSK appoints Charles Bancroft to the Board as a Non-Executive Director